This firm's average rating is Strong Buy from 2 analysts. We provide investment recommendation to complement the last-minute expert consensus on Marker Therapeutics. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the entity's potential to grow using all technical and fundamental data available at the time.